Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.26
(0.83%)
CNY 7.26
(0.83%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.36 Million CNY | -111.34% |
| 2022 | 100.28 Million CNY | -48.7% |
| 2021 | 195.48 Million CNY | 49.28% |
| 2020 | 130.95 Million CNY | -43.06% |
| 2019 | 230 Million CNY | -42.79% |
| 2018 | 402 Million CNY | -12.73% |
| 2017 | 460.64 Million CNY | -27.08% |
| 2016 | 631.72 Million CNY | 5.25% |
| 2015 | 600.18 Million CNY | 252.54% |
| 2014 | 170.24 Million CNY | 157.65% |
| 2013 | -295.29 Million CNY | 65.12% |
| 2012 | -846.72 Million CNY | 3.66% |
| 2011 | -878.85 Million CNY | -38265.86% |
| 2010 | -2.29 Million CNY | 88.02% |
| 2009 | -19.11 Million CNY | -133.87% |
| 2008 | 56.44 Million CNY | 132.82% |
| 2007 | 24.24 Million CNY | -35.51% |
| 2006 | 37.59 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 358.89 Million CNY | 497.98% |
| 2024 Q3 | 361.45 Million CNY | 1.76% |
| 2024 Q1 | -90.17 Million CNY | -693.14% |
| 2023 Q3 | 34.77 Million CNY | -35.94% |
| 2023 Q1 | 46.11 Million CNY | -54.02% |
| 2023 FY | -11.36 Million CNY | -111.34% |
| 2023 Q4 | -11.36 Million CNY | -132.7% |
| 2023 Q2 | 54.28 Million CNY | 17.73% |
| 2022 Q3 | 153.34 Million CNY | 8.83% |
| 2022 Q1 | 214.27 Million CNY | 9.61% |
| 2022 Q4 | 100.28 Million CNY | -34.61% |
| 2022 FY | 100.28 Million CNY | -48.7% |
| 2022 Q2 | 140.9 Million CNY | -34.24% |
| 2021 Q1 | 147.73 Million CNY | 12.81% |
| 2021 Q2 | 102.75 Million CNY | -30.45% |
| 2021 Q3 | 116.85 Million CNY | 13.72% |
| 2021 FY | 195.48 Million CNY | 49.28% |
| 2021 Q4 | 195.48 Million CNY | 67.3% |
| 2020 Q1 | 204.26 Million CNY | -11.19% |
| 2020 Q2 | 217.48 Million CNY | 6.47% |
| 2020 Q3 | 179.52 Million CNY | -17.46% |
| 2020 Q4 | 130.95 Million CNY | -27.05% |
| 2020 FY | 130.95 Million CNY | -43.06% |
| 2019 Q2 | 300.64 Million CNY | -10.83% |
| 2019 Q1 | 337.17 Million CNY | -16.13% |
| 2019 FY | 230 Million CNY | -42.79% |
| 2019 Q3 | 302.04 Million CNY | 0.46% |
| 2019 Q4 | 230 Million CNY | -23.85% |
| 2018 Q1 | 451.3 Million CNY | -2.03% |
| 2018 FY | 402 Million CNY | -12.73% |
| 2018 Q4 | 402 Million CNY | -8.23% |
| 2018 Q3 | 438.04 Million CNY | -4.23% |
| 2018 Q2 | 457.4 Million CNY | 1.35% |
| 2017 Q2 | 547.27 Million CNY | -2.11% |
| 2017 Q3 | 524.15 Million CNY | -4.22% |
| 2017 Q4 | 460.64 Million CNY | -12.12% |
| 2017 FY | 460.64 Million CNY | -27.08% |
| 2017 Q1 | 559.06 Million CNY | -11.5% |
| 2016 Q4 | 631.72 Million CNY | 4.35% |
| 2016 Q3 | 605.37 Million CNY | 0.9% |
| 2016 Q2 | 599.95 Million CNY | 10.22% |
| 2016 FY | 631.72 Million CNY | 5.25% |
| 2016 Q1 | 544.33 Million CNY | -9.31% |
| 2015 FY | 600.18 Million CNY | 252.54% |
| 2015 Q2 | 586.96 Million CNY | 11.47% |
| 2015 Q1 | 526.54 Million CNY | 209.29% |
| 2015 Q4 | 600.18 Million CNY | 4.67% |
| 2015 Q3 | 573.4 Million CNY | -2.31% |
| 2014 Q3 | -25.3 Million CNY | 73.64% |
| 2014 Q1 | -157.07 Million CNY | 46.81% |
| 2014 FY | 170.24 Million CNY | 157.65% |
| 2014 Q4 | 170.24 Million CNY | 772.76% |
| 2014 Q2 | -95.98 Million CNY | 38.89% |
| 2013 Q3 | -418.59 Million CNY | 31.45% |
| 2013 Q2 | -610.66 Million CNY | 30.38% |
| 2013 Q1 | -877.19 Million CNY | -3.6% |
| 2013 FY | -295.29 Million CNY | 65.12% |
| 2013 Q4 | -295.29 Million CNY | 29.45% |
| 2012 Q4 | -846.72 Million CNY | -5.12% |
| 2012 Q3 | -805.46 Million CNY | 4.48% |
| 2012 Q2 | -843.21 Million CNY | 4.45% |
| 2012 Q1 | -882.44 Million CNY | -0.41% |
| 2012 FY | -846.72 Million CNY | 3.66% |
| 2011 Q3 | -910.22 Million CNY | 5.72% |
| 2011 FY | -878.85 Million CNY | -38265.86% |
| 2011 Q2 | -965.48 Million CNY | 5.29% |
| 2011 Q1 | -1.01 Billion CNY | -44400.77% |
| 2011 Q4 | -878.85 Million CNY | 3.45% |
| 2010 Q4 | -2.29 Million CNY | 0.0% |
| 2010 FY | -2.29 Million CNY | 88.02% |
| 2009 FY | -19.11 Million CNY | -133.87% |
| 2009 Q2 | 26.44 Million CNY | 0.0% |
| 2009 Q4 | -19.11 Million CNY | 0.0% |
| 2008 FY | 56.44 Million CNY | 132.82% |
| 2007 FY | 24.24 Million CNY | -35.51% |
| 2006 FY | 37.59 Million CNY | 0.0% |